Healthcare Industry News: GEM Premier
News Release - April 27, 2011
Instrumentation Laboratory Appoints Ramon E. Benet New Chief Executive OfficerIndustry Veteran to Steer Leading In Vitro Diagnostics Company
BEDFORD, Mass., April 27, 2011 -- (Healthcare Sales & Marketing Network) -- Instrumentation Laboratory (IL) today announced the appointment of Ramon E. Benet as its Chief Executive Officer, effective May 1, 2011. Mr. Benet began his career with IL in 1993 and was most recently Senior Vice President of Worldwide Marketing, Sales and Service.
Mr. Benet succeeds Josep Manent who served as CEO since 1999. Under Mr. Manent's leadership, IL re-engineered its product development process and released new and innovative products, resulting in growth more than double that of the industry.
"Josep and Ramon have worked very closely together over the last decade, bringing extraordinary experience, capabilities and commitment to IL," said Salvador Casases, Chief Executive Officer at Werfen Group, IL's parent company. "Therefore, we have great confidence that with Ramon at the helm, we will continue to have strong guidance, strategic insight and direction to maintain IL's leadership position in the industry."
"I am extremely energized by this appointment," said Ramon Benet. "IL is in a very strong position, both in the Critical Care and Hemostasis diagnostic markets. Opportunities abound for us and I look forward to working with the senior leadership team to further our upward trajectory."
Mr. Benet has over twenty-five years of experience in marketing and sales in the in vitro diagnostics and consumer goods industries. Prior to joining IL, he held marketing and sales positions of increasing responsibility for Centocor Diagnostics, Ortho Diagnostic Systems and Ciba-Geigy (now Novartis). Mr. Benet holds a law degree from the University of Barcelona and an MBA from IESE, University of Navarra, both in Spain.
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM® product offerings, part of the critical care line, include the GEM Premier™ 4000 analyzer with Intelligent Quality Management (iQM®), GEM Premier 3500, GEMweb® Plus Custom Connectivity, and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP 700, the new ACL TOP 700 LAS and the ACL TOP 500 CTS. IL also offers the new ACL AcuStar™, ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents. IL is based in Bedford, Massachusetts.
The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.
Source: Instrumentation Laboratory
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.